Carbidopa and Levodopa - CARBIDOPA and LEVODOPA
Navigation: NDC > Supplier starting with: G > GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.| Field | Value |
|---|---|
| NDC Code: | 0115-3911 |
| Proprietary Name: | Carbidopa and Levodopa |
| Suffix: | |
| Non-Proprietary Name: | CARBIDOPA and LEVODOPA |
| Dosage Form: | TABLET, EXTENDED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 14-05-2004 |
| Category Name: | ANDA |
| Application Number: | ANDA076521 |
| Labeler: | GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC. |
| Substance Name: | CARBIDOPA; LEVODOPA |
| Active Numerator Strength: | 50; 200 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |
| DEA Schedule: |